ST
TNDM icon

Spot Trading’s Tandem Diabetes Care TNDM Stock Holding History

Spot Trading’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,000
Closed -$268K – 4404
2014
Q3 		$268K Buy
+2,000
New +$280K ﹤0.01% 2981

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Spot Trading's TNDM Position: Q4 2014 in Review

Spot Trading sold out of Tandem Diabetes Care (TNDM) in Q4 2014, closing a stake of 631 shares — an estimated $85K sold.

Spot Trading first reported a position in TNDM in Q3 2014 and held it in 1 quarter. The position peaked at $85K in Q3 2014. 66 funds tracked by Wall St. Rank hold TNDM as of Q4 2014.

  • Spot Trading reported no remaining Tandem Diabetes Care position as of Q4 2014 after selling out during the quarter.
  • Spot Trading sold 631 Tandem Diabetes Care shares in Q4 2014, an estimated $85K.
  • Spot Trading first reported a position in Tandem Diabetes Care in Q3 2014 and held it in 1 quarter.
  • Spot Trading's Tandem Diabetes Care position peaked at $85K in Q3 2014.
  • 66 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2014.

Based on Spot Trading's 13F filing for Q4 2014, filed 13 Feb 2015.